Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond K Cross

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 20, 2016
Integration of Telemedicine Into Clinical Gastroenterology and Hepatology PracticeRaymond K Cross, Sunanda Kane
Expert Opinion on Drug Safety|July 4, 2015
Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitisMatilda Hagan, Raymond K Cross
Digestive Diseases and Sciences|January 11, 2007
Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot studyRaymond K Cross, Joseph Finkelstein
Expert Opinion on Emerging Drugs|November 12, 2022
Emerging drugs for the treatment of inflammatory bowel diseaseUni Wong, Raymond K Cross
Gastroenterology & Hepatology|April 29, 2024
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and ConsequencesPreetika Sinh, Raymond K Cross
Southern Medical Journal|March 28, 2003
Two cases of spontaneous epidural abscess in patients with cirrhosisRaymond K Cross, Charles Howell
Inflammatory Bowel Diseases|January 17, 2020
Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?Uni Wong, Raymond K Cross
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 24, 2018
Improving Outcomes in Patients With Inflammatory Bowel Disease Through Integrated Multi-Disciplinary Care-the Future of IBD CareKaci Christian, Raymond K Cross
Expert Opinion on Drug Metabolism & Toxicology|September 7, 2017
Primary and secondary nonresponse to infliximab: mechanisms and countermeasuresUni Wong, Raymond K Cross
Expert Opinion on Investigational Drugs|March 19, 2019
Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel diseaseUni Wong, Raymond K Cross
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 20, 2016
Integration of Telemedicine Into Clinical Gastroenterology and Hepatology PracticeRaymond K Cross, Sunanda Kane
Expert Opinion on Drug Safety|July 4, 2015
Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitisMatilda Hagan, Raymond K Cross
Digestive Diseases and Sciences|January 11, 2007
Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot studyRaymond K Cross, Joseph Finkelstein
Expert Opinion on Emerging Drugs|November 12, 2022
Emerging drugs for the treatment of inflammatory bowel diseaseUni Wong, Raymond K Cross
Gastroenterology & Hepatology|April 29, 2024
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and ConsequencesPreetika Sinh, Raymond K Cross
Southern Medical Journal|March 28, 2003
Two cases of spontaneous epidural abscess in patients with cirrhosisRaymond K Cross, Charles Howell
Inflammatory Bowel Diseases|January 17, 2020
Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?Uni Wong, Raymond K Cross
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 24, 2018
Improving Outcomes in Patients With Inflammatory Bowel Disease Through Integrated Multi-Disciplinary Care-the Future of IBD CareKaci Christian, Raymond K Cross
Expert Opinion on Drug Metabolism & Toxicology|September 7, 2017
Primary and secondary nonresponse to infliximab: mechanisms and countermeasuresUni Wong, Raymond K Cross
Expert Opinion on Investigational Drugs|March 19, 2019
Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel diseaseUni Wong, Raymond K Cross
Pageof 21